| ASSET | YEAR | % RETURN |
|---|---|---|
AN2 Therapeutics (ANTX) | 2022 | -43.44% |
AN2 Therapeutics (ANTX) | 2023 | 115.46% |
AN2 Therapeutics (ANTX) | 2024 | -93.15% |
AN2 Therapeutics (ANTX) | 2025 | -17.99% |
AN2 Therapeutics (ANTX) | 2026 | 298.21% |
| ASSET | YEAR | % RETURN |
|---|---|---|
AN2 Therapeutics (ANTX) | 2022 | -43.44% |
AN2 Therapeutics (ANTX) | 2023 | 115.46% |
AN2 Therapeutics (ANTX) | 2024 | -93.15% |
AN2 Therapeutics (ANTX) | 2025 | -17.99% |
AN2 Therapeutics (ANTX) | 2026 | 298.21% |